Zevra Therapeutics (ZVRA) Other Non Operating Income (2014 - 2026)

Zevra Therapeutics (ZVRA) has 6 years of Other Non Operating Income data on file, last reported at -$7.2 million in Q1 2026.

• Quarterly Other Non Operating Income changed N/A year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$144.3 million (down 5689.47% YoY) and the FY2025 annual result came in at -$133.7 million, down 2254.24% from the prior year.
• Other Non Operating Income advanced to -$7.2 million in Q1 2026, from -$265.9 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $135.4 million in Q2 2025 to a low of -$265.9 million in Q4 2025.
• A 3-year average of -$18.2 million and a median of -$5.1 million in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 7470.08% in 2025, down 3630.87% in 2025.
• Tracing ZVRA's Other Non Operating Income over 3 years: stood at $7.5 million in 2024, then sank by 3630.87% to -$265.9 million in 2025, then jumped by 97.29% to -$7.2 million in 2026.
• The last three Other Non Operating Income figures came in at -$7.2 million (Q1 2026), -$265.9 million (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.